Back
Product details:
CAS
388082-78-8
Purity
95%
Lapatinib ditosylate is a potent inhibitor of the ErbB-2 and EGFR tyrosine kinase domains. Formulations containing lapatinib have been used in combination with other therapeutics in the treatment of HER2-overexpressing breast cancer.
Properties
Name
Lapatinib ditosylate
Smiles
CC=1C=CC(=CC1)S(=O)(=O)O.CC=1C=CC(=CC1)S(=O)(=O)O.CS(=O)(=O)CCNCC1=CC=C(O1)C=2C=CC=3N=CN=C(NC=4C=CC(OCC=5C=CC=C(F)C5)=C(Cl)C4)C3C2
Targets
Please log in to see this information
SDS
GW-572016 | lapatinib di-p-toluenesulfonate | lapatinib ditosylate | tykerb
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$19
2 mg
$19
5 mg
$19
10 mg
$19
15 mg
$19
20 mg
$19
25 mg
$19
30 mg
$19
35 mg
$19
40 mg
$19
45 mg
$19
50 mg
$19
75 mg
$19
100 mg
$POA
Quantity
1
Total amount
$ 19
GW-572016 | lapatinib di-p-toluenesulfonate | lapatinib ditosylate | tykerb
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.